key: cord-0801634-o2tyhklo
authors: Kumarasinghe, M.; Kasturiaratchi, K.; Jayakody, H.; Irfaan, S.; Samarasinghe, W.; Dassanayake, H.; Godakandage, S.; de Silva, C.
title: Neonatal and Maternal Outcome of COVID-19 positive women in Sri Lanka: Secondary Analysis using National COVID-19 Positive Pregnant Women Surveillance
date: 2022-02-13
journal: nan
DOI: 10.1101/2022.02.10.22270732
sha: 7c9a7e56cb3f243b1a649d1b5a2512d22a8e5c37
doc_id: 801634
cord_uid: o2tyhklo

Objectives This study aims to describe the population level data on neonatal and maternal outcomes of COVID-19 positive pregnant women of Sri Lanka by secondary analysis using National COVID-19 Positive Pregnant Women Surveillance. Design Secondary analysis of surveillance data from the National COVID-19 positive pregnant women surveillance, Sri Lanka. Data of all pregnant women whose maternal and neonatal outcomes were reported in National Surveillance from 1st March 2020 to 31st October 2021 were included in the study. Associated factors for maternal and neonatal outcomes, namely POA at delivery, mode of delivery, birthweight, immediate place of newborn care, congenital abnormalities, and condition of neonate at completion of one month were calculated using univariate and multivariate Odds ratios. Results Maternal COVID-19 infection reported preterm birth rate of 11.9%, LSCS rate of 54.5%, low birthweight rate16.5% and 8.3% of the newborns requiring intensive care. Neonatal mortality rate was 9 per 1000 live births. Pre-pregnancy overweight and obesity increased the risk of preterm delivery compared to pregnant women with normal BMI by 46.7% (AOR=1.467, CI=1.111-1.938, P=0.007). In contrast, the risk of preterm delivery reduced by 82.4% (AOR=0.176, CI=0.097-0.317, p<0.001) and presence of any type of congenital abnormalities in newborns by 72.4% among the COVID-19 positive women who required only inward treatment in comparison to women with severe COVID-19 infection requiring intensive care (AOR=0.276, CI=0.112-0.683, p=0.005). Conclusion Increased severity of maternal COVID-19 infection and pre-pregnancy overweight/ obesity were associated with many adverse pregnancy and neonatal outcomes. Therefore, close observation and aggressive management of COVID-19 among the pregnant women should be considered to reduce the risk of progressing to severe illness.

In 2019, the novel coronavirus SARS-CoV-2 pandemic originated in Hubei Province of People's Republic of China. Within few months COVID-19 spread globally with majority of nations reporting cases. WHO Emergency Committee declared COVID-19 as a global health emergency on 30 th January 2020 and 11th March 2020 as a pandemic. [1] At the early stages of the pandemic, minimal knowledge existed on pregnancy and newborn outcomes of maternal COVID-19 infection unlike the understanding on disease severity and clinical profile. However, with the continuation of the pandemic, evidence on maternal and newborn outcomes in maternal COVID-19 gradually emerged. Many studies have highlighted the possibility of numerous adverse maternal and perinatal outcomes following COVID-19

infection. [2] [3] [4] [5] [6] Possible adverse maternal and perinatal outcomes include increased risk of preeclampsia, maternal death, disseminated intravascular coagulopathy, intrauterine fetal demise, intrauterine growth restriction, preterm delivery, spontaneous abortion, preterm birth and stillbirth.

Further, systematic reviews further concluded that severe maternal COVID-19 infection significantly increase these adverse outcomes compared to mild to moderate infection.

An overview of systematic reviews reported that cesarean section is the preferred mode of delivery which ranged from 52.3% to 95.8%. [7] Further, the study team reported the preterm delivery rate between 14.3% to 63.8%. Stillbirth rate reported to be less than 2.5% and low birthweight between 5.3% to 47.4%. NICU admission of the newborns of COVID-19 positive pregnant women ranged from 3.1% to 76.9% with neonatal mortality rate did not exceed 3%. Despite the inclusion of 39 systematic reviews, the wide range of rates in pregnancy and neonatal outcomes highlight the nonagreement of the scientific community on the effect of maternal COVID-19 on pregnancy and neonatal outcomes. [7] The literature revealed wide range in rates of pregnancy and neonatal outcomes in maternal COVID-19 infection, not only among the different studies but also in different geographical locations. [8] [9] Systemic review by Dubey et al. revealed that deliveries by cesarean sections were higher among Chinese communities in comparison to American and European communities (91% vs. 40% and 38% respectively). Similarly higher rates of adverse pregnancy outcomes were reported in Chinese studies compared to American and European studies (21% vs 15% and 19% respectively). Further, the same systematic review showed reginal variation in preterm delivery.

(American studies vs. Chinese and European studies: 12% vs. 17% and 19% respectively). [8] These findings highlight the importance of local evidence for the management of pregnancy and neonatal outcomes of maternal COVID-19.

Though scientific information has emerged in developed countries on impact on COVID-19 maternal infection on pregnancy and newborn outcomes, the scarcity of information in developing countries, particularly in South Asia is a concern. In Sri Lanka, no literature is available on the pregnancy and newborn outcomes following maternal COVID-19 infection. Further, limited understanding prevails on factors which increase the risk of adverse pregnancy and neonatal outcomes in maternal COVID-19 infection. Therefore, this study was intended to answer 3 main questions related to pregnancy and newborn outcomes following maternal COVID-19 in Sri In this study, we aimed to describe the maternal, neonatal and COVID-19 disease related characteristics among the COVID-19 positive pregnant women in Sri Lanka using data from national COVID-19 positive pregnant women surveillance. In addition, the association of pregnancy and neonatal outcome variables were assessed with selected sociodemographic, maternal, pregnancy and COVID-19 disease related factors.

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. 

Age in years (grouped according to less than 35 years and 35 years or more), ethnicity, sector (urban, rural and estate according to the definition by the department of Census and Statistics) and monthly family (household) income according to the poverty line, median and mean household income. [11] [12] .

Selected maternal characteristics include the pre-pregnancy BMI grouped as low, normal and overweight (and obesity), comorbidities, namely chronic DM, chronic hypertension, cardiovascular disease, chronic respiratory disease.

Pregnancy characteristics selected for the study include the presence of gestational DM, pregnancy induced HT, gravida, parity, number of living children, POA at delivery (preterm birth or not), mode of delivery (vaginal delivery or cesarian section). Neonatal characteristics include birthweight grouped according to WHO classification, place of immediate newborn care (postnatal ward or premature baby unit/ neonatal intensive care unit), initiation of breast feeding within one hour of birth, detection of any congenital abnormalities and neonate live or not at the end of neonatal period. [13] COVID-19 related measures . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted February 13, 2022. ; https://doi.org/10.1101/2022.02.10.22270732 doi: medRxiv preprint

Data extraction of all eligible COVID-19 positive pregnant women was carried out from the national surveillance (Eligibility-In the national surveillance, completed segments number one, two and three of the data extraction form by 31st October 2021) was extracted. Data was initially transferred to MS Excel software; they were coded and analysed using Statistical Package for Social Sciences (SPSS) 22 version. Rates were presented as proportions. Statistical significance was calculated based on a p value of less than 0.05 was considered as statistically significant. All variables were used to perform the multivariate analysis using logistic regression (enter method) irrespective of their significance in bivariate analysis to identify multivariate ORs and their Confidence Intervals. For monthly family (household) income, poverty line, median and mean household incomes were used for categorization. Pre-pregnancy overweight among the COVID-19 positive pregnant women stood at 35.7%. Only 31% reported receiving at least single dose of any type of COVID-19 vaccine. Incidence of . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted February 13, 2022. ; https://doi.org/10.1101/2022.02.10.22270732 doi: medRxiv preprint Gestational DM was at 8% whereas Pregnancy Induced Hypertension was reported as 3% among the COVID-19 positive pregnant women (Table 1) .

COVID-19 positive pregnant women showed preterm birth of 11.9% and LSCS rate at 54.5%.

Low birthweight rate was 16.5% with 8.3% of the newborns were admitted to either Premature Baby Unit or Neonatal Intensive Care Unit. Neonatal mortality rate was reported at 9 per 1000 live births among the COVID-19 positive pregnant women ( Table 2) . . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted February 13, 2022. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted February 13, 2022. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. Table 4 ). . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted February 13, 2022. Table 6) .

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted February 13, 2022. ; Table 7 ). . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted February 13, 2022. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. 

As reported by Kumarasinghe et al. , percentage of pregnant women who were 35 years or older was 13.6% in Sri Lanka in 2020-2021 whereas present study revealed 17.9% of pregnant women in same age group highlighting the increase incidence of symptomatic COVID-19 infection with advancing age in Sri Lanka. [15] However, studies in America and Italy have suggested significant decrease in incidence of COVID-19 among the 35 years or above category in similar population based studies. [16] [17] Onset and coverage of vaccination of pregnant women could be a factor in the observed difference. Though the countries like America and Italy initialed vaccinating pregnant women earlier than Sri Lanka, the coverage is an issue with large number of youth avoiding vaccination in America and Europe. [18] [19] . In Sri Lanka, it is reported that around 80% to 90% of pregnant women in Sri Lanka was vaccinated against COVID-19 by September of 2021 being the first country in South Asia to commence vaccinating pregnant women ( Among the COVID-19 positive women only 31% have received at least a single dose of any recommended vaccine before 14 days of the diagnosis. [20] . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted February 13, 2022. ; https://doi.org/10.1101/2022.02.10.22270732 doi: medRxiv preprint

Preterm delivery rate(less than 37 weeks) in the present study among COVID-19 positive pregnant women was 11.9%. Published national preterm rates are not available for Sri Lanka. Many studies reported higher rates of preterm delivery among COVID-19 positive women compared to the present study. However, these studies were not population based studies and were confined to a single or multiple centers. These studies have only included pregnant women who were either tested positive on admission for the delivery or delivered during the hospital stay following admission to hospital with the diagnosis of COVID-19. Pre-term delivery rates ranged from 13.8% to 59.4%. [8, [21] [22] [23] [24] [25] Present study showed increased risk of preterm delivery among the pregnant women with severe COVID-19 infection. Conflicting evidence have emerged on whether the severity of the maternal

States concluded that acute COVID-19 severity was not correlated with gestational age at delivery whereas separate cohort study in United States reported significant increase in preterm delivery among critical group compared to severe group. [22, 26] Our study reported preterm delivery rate of 40.7% among pregnant women needing ICU/ ECMO/ ventilated/ death whereas Pierce-Williams reported preterm delivery rate of 27% among severe group and 88% among critical group. [22] 

Preferred mode of delivery of the COVID-19 positive pregnant women in Sri Lanka was cesarean section with 54.5% undergoing CS. The cesarean section rate of this study is among the one the highest among the published studies with large sample sizes. Not only among COVID-19 positive pregnant women, but national CS rate in Sri Lanka is also one of the highest in the world which might have contributed the increased CS rate of maternal COVID-19. [27] [28] The CS rate among COVID-19 positive pregnant women ranged from 22.4% in America to 94% in China. Some of these studies included less than 100 respondents. [8, [21] [22] [23] 26] . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted February 13, 2022. ; https://doi.org/10.1101/2022.02.10.22270732 doi: medRxiv preprint Similar to the general population of pregnant women, pre-pregnancy overweight and obesity increased the chances of cesarean section among the maternal COVID-19 positive women in our study population. Significant increase in the CS rates were observed in United States cohort study with increase in severity of maternal COVID-19 infection in consistent with our study findings. [22] Birthweight of the newborn Present study revealed low birthweight of 16.5%. Range of low birthweight reported by studies ranged from 5% to 67%. Many reasons could have contributed to this wide range. One could be the characteristics of the sample including the proportion of severe to critical women. Second, the inclusion criteria; Whether all women of past and present COVID-19 infection or only the women with active infection during the delivery was included. Third, the study setting, with some were institutional based whereas few were population based. Sample size also could have played a role in difference. However, it is important to compare the reported low birthweight rates with the national averages as many factors including sociodemographic factors play an important role in determining the low birthweight among COVID-19 positive pregnant women. Sri Lanka reported low birthweight of 16% in 2018. [28] Thus, only 0.5% increase in low birthweight was observed in the present study. [7-8, 25, 29-32] Increase severity was associated with higher low birthweight rates as concluded by studies including the present one. [22] Our study revealed significantly higher rates of low birth weight among older pregnant women which is a known risk factor for low birthweight irrespective of the presence of COVID-19 among pregnant women. However, Dubey et al. in their meta-analysis failed to demonstrate statistical difference though the age categorization differed from the present study (35 or more vs. more than 30 years). [8, 33] Immediate Postnatal care and presence of congenital abnormalities

As described under "birthweight of the newborn" many variations in study design, population, study setting and sample size have contributed to wide range of reporting rates of intensive . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted February 13, 2022. ; https://doi.org/10.1101/2022.02.10.22270732 doi: medRxiv preprint postnatal care among maternal COVID-19 infection from 8.3% (present study) to 76.9%. [22-23, 30, 32, 34-35] Similar to present study, increased severity was associated with higher possibility of admission to intensive care for postnatal management of the newborn. [22] Further present study reported newborns of overweight/ obese pregnant women are at higher probability of admission to intensive care postnatally. Pre-pregnancy obesity in a known independent risk factor for neonatal intensive care admission. Therefore, the observed increased neonatal admission could be due to overweight/ obesity irrespective of the maternal COVID-19 status. [36] Our study reported incidence of congenital abnormalities of any type and severity at 3.2%. The national birth effect rate was less than 2%. Therefore, there could be a possibility of increased incidence of congenital abnormalities among the newborns of COVID-19 positive pregnant women. At present, limited literature is available that provide clear direction on congenital abnormalities and COVID. Thus, further research is needed to have a clear picture. [37] [38] CONCLUSION Increased severity of COVID-19 pregnant women was associated with many adverse pregnancy and neonatal outcomes including increased cesarean section rates, preterm delivery, low birthweight and congenital abnormalities compared to less severe infection. Similarly, prepregnancy overweight/ obesity could increase the risk of many negative pregnancy and neonatal outcomes compared to pregnant women with normal BMI. Thus, close observation and management of COVID-19 among the pregnant women should be considered to reduce the risk of progressing to severe illness. This could have an impact in reducing the adverse pregnancy and neonatal outcomes among maternal COVID-infection.

World Health Organization. Coronavirus disease (COVID-19) pandemic

Obstetrical outcomes and maternal morbidities associated with COVID-19 in pregnant women in France: A national retrospective cohort study

COVID-19 in pregnancy: Risk of adverse neonatal outcomes

COVID-19 in pregnancy: Placental and neonatal involvement

COVID-19: neonatal-perinatal perspectives

International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity

The impact of COVID-19 on pregnancy outcomes: a systematic review and meta-analysis

Maternal and Neonatal Characteristics and Outcomes of COVID-19 in Pregnancy: An Overview of Systematic Reviews

Maternal and neonatal characteristics and outcomes among COVID-19 infected women: An updated systematic review and meta-analysis

COVID-19 infection in pregnant women: Review of maternal and fetal outcomes

Information on COVID-19 positive pregnant mothers in the field-FHB/EU/Gen/2021 dated 07 th

Department of Census and Statistics. Census of Population and Housing

International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity

ICD-10 : international statistical classification of diseases and related health problems : tenth revision

Guidelines for Management of Pregnant and Postpartum COVID-19 patients-FHB/MCU/COVID/2021 dated 30 th

Secondary Analysis of Maternal Characteristics and Pregnancy Outcomes of COVID-19 Positive Pregnant Women in Sri Lanka Using National COVID-19 Positive Pregnant Women Surveillance

Sociodemographic characteristics of pregnant women tested positive for COVID-19 admitted to a referral center in Northern Italy during lockdown period

COVID-19 prevalence, symptoms, and sociodemographic disparities in infection among insured pregnant women in Northern California

COVID-19 and pregnancy: Staying safe, giving birth and getting vaccinated

COVID-19 Vaccination Coverage Among Pregnant Women During Pregnancy -Eight Integrated Health Care Organizations, United States

International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity

Most pregnant women vaccinated now -FHB. Daily News

The association between SARS-CoV-2 infection and preterm delivery: a prospective study with a multivariable analysis

Clinical course of severe and critical coronavirus disease 2019 in hospitalized pregnancies: a United States cohort study

Coronavirus disease 2019 in pregnancy was associated with maternal morbidity and preterm birth

Impact of COVID-19 on maternal and neonatal outcomes: a systematic review and meta-analysis

Outcome of coronavirus spectrum infections (SARS, MERS, COVID-19) during pregnancy: a systematic review and meta-analysis

The effect of maternal SARS-CoV-2 infection Health

The caesarean section rate is rising

Colombo: Family Health Bureau

COVID-19 and pregnancy: An umbrella review of clinical presentation, vertical transmission, and maternal and perinatal outcomes

Maternal and neonatal outcomes associated with COVID-19 infection: A systematic review

Pregnancy and COVID-19: a systematic review of maternal, obstetric and neonatal outcomes

Maternal clinical characteristics and perinatal outcomes among pregnant women with coronavirus disease 2019. A systematic review

Is maternal age risk factor for low birth weight?

A systematic review and meta-analysis of data on pregnant women with confirmed COVID-19: Clinical presentation, and pregnancy and perinatal outcomes based on COVID-19 severity

The effect of coronavirus infection (SARS-CoV-2, MERS-CoV, and SARS-CoV) during pregnancy and the possibility of vertical maternalfetal transmission: a systematic review and meta-analysis

Neonatal outcomes in obese mothers: a population-based analysis

Birth Defects in Sri Lanka. World Health Organization

COVID-19 in pregnancy: the foetal perspective-a systematic review

We acknowledge all the front-line public health staff, namely field Public Health Midwives, Public Health Nursing Sisters, Medical Officers of Health and regional health managers, namely Medical 

Ethical approval was obtained from Ethics Review Committee of Faculty of Medical Sciences, University of Sri Jayawardenepura (COVID 11/21).

Data are available on reasonable request. Raw data without personal identifiers are available from corresponding author on reasonable request.